Evidence map›Paper›PMID 35562529›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

Prognostic value of immunotherapy-induced organ inflammation assessed on

Olivier Humbert, Matteo Bauckneht, Jocelyn Gal, Marie Paquet, David Chardin, David Rener, Aurelie Schiazza, Carlo Genova, Renaud Schiappa, Lodovica Zullo and 6 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. The Prognostic Value of Biomarkers Identified by [Diagnostics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. [European journal of nuclear medicine and molecular imaging · 2024
    Article
  4. Immune-related [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  5. Article
  6. IsCancers · 2024
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Olivier HumbertDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06189, Nice, France. olivier.humbert@univ-cotedazur.fr.ORCID 0000-0003-4440-5416
Matteo BaucknehtNuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Jocelyn GalDepartment of Biostatistics, Centre Antoine-Lacassagne, Nice, France.
Marie PaquetDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06189, Nice, France.
David ChardinDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06189, Nice, France.
David RenerDepartment of Biostatistics, Centre Antoine-Lacassagne, Nice, France.
Aurelie SchiazzaDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06189, Nice, France.
Carlo GenovaUOC Clinica Di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Renaud SchiappaDepartment of Biostatistics, Centre Antoine-Lacassagne, Nice, France.
Lodovica ZulloDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Giovanni RossiDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Nicolas MartinDepartment of Medical Oncology, Centre Antoine-Lacassagne, UCA, Nice, France.
Florent HugonnetDepartment of Nuclear Medicine, Centre Hospitalier Princesse Grâce, Monaco, Monaco.
Jacques DarcourtDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06189, Nice, France.
Silvia MorbelliNuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Josiane OttoDepartment of Medical Oncology, Centre Antoine-Lacassagne, UCA, Nice, France.
Centre Antoine Lacassagne · FRUniversité Côte d'Azur · FROspedale Policlinico San Martino · ITUniversity of Sassari · ITCenter for Economic and Policy Research · USPrincess Grace Hospital Centre · MC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe evaluated the prognostic value of immunotherapy-induced organ inflammation observed on

methodsData from patients with IIIB/IV NSCLC included in two different prospective trials were analyzed.

resultsExploratory cohort (Nice, France): PET

conclusionImmuno-induced gastritis revealed by early interim

Indexed as

Carcinoma, Non-Small-Cell LungGastritisLung NeoplasmsFluorodeoxyglucose F18HumansImmunologic FactorsImmunotherapyInflammationPositron Emission Tomography Computed TomographyPrognosisProspective StudiesRetrospective StudiesFluorodeoxyglucose F18Immunologic FactorsAdverse eventsBiomarkerFDG PETImmunotherapyLung cancer

Identifiers

PMID35562529
PMCPMC9399195
OpenAlexW4280520316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.